Jonathan Chang

Stock Analyst at Leerink Partners

(0)
# 5111
Out of 5,441 analysts
134
Total ratings
Success rate
Average return
25 Stocks
Name Action PT Current % Upside Ratings Updated
REPL Replimune Group
Downgrades: Market Perform
21 3
4.98 -39.76% 10 Jul 22, 2025
ZLAB Zai Lab
Maintains: Outperform
73 75
34.65 116.45% 9 Jun 30, 2025
GMAB Genmab
Upgrades: Outperform
27
21.08 28.08% 10 Feb 13, 2025
VINC Vincerx Pharma
Maintains: Outperform
80 40
n/a n/a 6 Oct 8, 2024
IMCR Immunocore Hldgs
Initiates Coverage On: Outperform
74
31.9 131.97% 1 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
11
7.35 49.66% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
51
10.91 367.46% 1 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
90 75
3.73 1910.72% 12 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
6
21.55 -72.16% 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
12.5 12% 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
18 2
n/a n/a 6 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 40
23.01 73.84% 6 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
3 2
1.48 35.14% 7 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 50
7.46 570.24% 4 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
31 30
34.71 -13.57% 4 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
1.47 716.33% 8 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 1
n/a n/a 7 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
325 350
5.98 5752.84% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 26
6.34 310.09% 5 Jun 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
20 60
n/a n/a 5 May 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 3
n/a n/a 8 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
5 4
31.23 -87.19% 5 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
41 28
5.54 405.42% 3 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
57 53
7 657.14% 7 Aug 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
50 0
n/a n/a 2 May 10, 2018